Frequency of Vα24+CD161+ natural killer T cells and invariant TCRAV24-AJ18 transcripts in atopic and non-atopic individuals

Immunobiology

Volumn 208, Issue 4, 2003, Pages 367-380

  Prell, Christine ^a   Konstantopoulos, Nikolaos ^a   Heinzelmann, Beatrix ^a   Frankenberger, Bernhard ^b   Reinhardt, Dietrich ^a   Schendel, Dolores J ^b   Krauss Etschmann, Susanne ^a,b,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD161 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; UNCLASSIFIED DRUG; COMPLEMENTARY DNA; GAMMA INTERFERON; INTERLEUKIN 4; LECTIN; MEMBRANE ANTIGEN;

ADULT; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOPATHOGENESIS; MALE; MOLECULAR CLONING; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; VENOUS BLOOD; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; GENE REARRANGEMENT; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PHENOTYPE; T LYMPHOCYTE RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ADULT; ANTIGENS, SURFACE; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA, COMPLEMENTARY; GENE REARRANGEMENT, ALPHA-CHAIN T-CELL ANTIGEN RECEPTOR; GENES, T-CELL RECEPTOR ALPHA; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; LECTINS, C-TYPE; PHENOTYPE; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; TRANSCRIPTION, GENETIC;

EID: 0347756888     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00284     Document Type: Article

References (70)

1. Alm JS, Swartz J, Lilja G, Scheynius A and Pershagen G. 1999. Atopy in children of families with an antroposophic lifestyle. Lancet 353: 1485-1488.
2. Apostolou I, Cumano A, Gachelin G and Kourilsky P. 2000. Evidence for two subgroups of CD4-CD8-NKT cells with distinct TCR alpha beta repertoires and differential distribution in lymphoid tissues. J. Immunol. 165: 2481-2490.
3. Arase H, Arase N and Saito T. 1996. Interferon gamma production by natural killer (NK) cells and NK1.1+T cells upon NKR-P1 cross-linking. J. Exp. Med. 183: 2391-2396.
4. Assarsson E, Kambayashi T, Sandberg JK, Hong S, Taniguchi M, Van-Kaer L, Ljunggren HG and Chambers BJ. 2000. CD8+T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J. Immunol. 165: 3673-3679.
5. Baxter AG, Kinder SJ, Hammond KJ, Scollay R and Godfrey DI. 1997. Association between alphabeta TCR + CD4 - CD8 - T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46: 572-582.
6. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR and Brutkiewicz RR. 1995. CD1 recognition by mouse NK1 + T lymphocytes. Science 268: 863-865.
7. Bendelac A, Hunziker RD and Lantz O. 1996. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184: 1285-1293.
8. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH and Holgate ST. 1994. Interleukin-4, -5 and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell. Mol. Biol. 10: 471-480.
9. Braun-Fahrländer C, Gassner M, Grize L, Neu U, Sennhauser FH, Varonier HS, Vuille JC and Wuthrich B. 1999. Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. SCARPOL team. Swiss Study on Childhood Allergy and Respiratory Symptoms with Respect to Air Pollution. Clin. Exp. Allergy 29: 28-34.
10. Brossay L, Naidenko O, Burdin N, Matsuda J, Sakai T and Kronenberg M. 1998. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J. Immunol. 161: 5124-5128.
11. - dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J. Immunol. 165: 3584-3591.
12. Chomczynski P and Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
13. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M and Taniguchi M. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
14. Davodeau F, Peyrat MA, Necker A, Dominici R, Blanchard F, Leget C, Gaschet J, Costa P, Jacques Y, Godard A, Vie H, Poggi A, Romagne F and Bonneville M. 1997. Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains. J. Immunol. 158: 5603-5611.
15. Dellabona P, Padovan E, Casorati G, Brockhaus M and Lanzavecchia A. 1994. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4 - 8 - T cells. J. Exp. Med. 180: 1171-1176.
16. Denkers EY, Scharton-Kersten T, Barbieri S, Caspar P and Sher A. 1996. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection. J. Exp. Med. 184: 131-139.
17. Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE and O'Farrelly C. 1999. The human liver contains multiple populations of NK cells, T cells, and CD3+ CD56+ Natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol. 163: 2314-2321.
18. Dretzen G, Bellard M, Sassone-Corsi P and Chambon P. 1981. A reliable method for the recovery of DNA fragments from agarose and acrylamide gels. Anal. Biochem. 112: 295-298.
19. Emoto M, Emoto Y, Buchwalow IB and Kaufmann SH. 1999. Induction of IFN-gamma-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Guerin. Eur. J. Immunol. 29: 650-659.
20. Emoto M, Zerrahn J, Miyamoto M, Perarnau B and Kaufmann SH. 2000. Phenotypic characterization of CD8(+)NKT cells. Eur. J. Immunol. 30: 2300-2311.
21. Exley M, Garcia J, Balk SP and Porcelli S. 1997. Requirements for CD1d recognition by human invariant Valpha24+ CD4 - CD8 - T cells. J. Exp. Med. 186: 109-120.
22. Finkelman FD, Morris SC, Orekhova T, Mori M, Donaldson D, Reiner SL, Reilly NL, Schopf L and Urban JF. 2000. Stat6 regulation of in vivo IL-4 responses. J. Immunol. 164: 2303-2310.
23. Flesch IE, Wandersee A and Kaufmann SH. 1997. IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis. J. Immunol. 159: 7-10.
24. Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD and Liu AH. 2000. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 355: 1680-1683.
25. Gombert JM, Tancrede-Bohin E, Hameg A, Leite-De-Moraes MC, Vicari A, Bach JF and Herbelin A. 1996. IL-7 reverses NK1+ T cell-defective IL-4 production in the non-obese diabetic mouse. Int. Immunol. 8: 1751-1758.
26. Gruber R, Reiter C and Riethmuller G. 1993. Triple immunofluorescence flow cytometry, using whole blood, of CD4+ and CD8+ lymphocytes expressing CD45RO and CD45RA. J. Immunol. Methods 163: 173-179.
27. Hammond KJ, Pelikan SB, Crowe NY, Randle-Barrett E, Nakayama T, Taniguchi M, Smyth MJ, van-Driel IR, Scollay R, Baxter AG and Godfrey DI. 1999. NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 29: 3768-3781.
28. Han M, Harrison L, Kehn P, Stevenson K, Currier J and Robinson MA. 1999. Invariant or highly conserved TCR α are expressed on double-negative (CD3 + CD4 - CD8 -) and CD8+ T cells. J. Immunol. 163: 301-311.
29. Hwang ES, White IA and Ho IC. 2002. An IL-4-independent and CD25-mediated function of c-maf in promoting the production of Th2 cytokines. Proc. Natl. Acad. Sci. USA 99: 13026-13030.
30. Illes Z, Kondo T, Newcombe J, Oka N, Tabira T and Yamamura T. 2000. Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy. J. Immunol. 164: 4375-4381.
31. Ishikawa H, Hisaeda H, Taniguchi M, Nakayama T, Sakai T, Maekawa Y, Nakano Y, Zhang M, Zhang T, Nishitani M, Takashima M and Himeno K. 2000. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12: 1267-1274.
32. Joyce S, Woods AS, Yewdell JW, Bennink JR, De Silva AD, Boesteanu A, Balk SP, Cotter RJ and Brutkiewicz RR. 1998. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 279: 1541-1544.
33. Kakimi K, Guidotti LG, Koezuka Y and Chisari FV. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192: 921-930.
34. Kitamura H, Ohta A, Sekimoto M, Sato M, Iwakabe K, Nakui M, Yahata T, Meng H, Koda T, Nishimura S, Kawano T, Taniguchi M and Nishimura T. 2000. α-Galactosylceramide induces early B-Cell activation through IL-4 production by NKT-cells. Cell. Immunol. 199: 37-42.
35. Kojo S, Adachi Y, Keino H, Taniguchi M and Sumida T. 2001. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 44: 1127-1138.
36. Laloux V, Beaudoin L, Jeske D, Carnaud C and Lehuen A. 2001. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 166: 3749-3756.
37. Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A, Bach JF and Monteiro RC. 1998. Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188: 1831-1839.
38. Leite-De-Moraes MC, Herbelin A, Machavoine F, Vicari A, Gombert JM, Papiernik M and Dy M. 1995. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response. J. Immunol. 155: 4544-4550.
39. Leite-De-Moraes MC, Moreau G, Arnould A, Machavoine F, Garcia C, Papiernik M and Dy M. 1998. IL4-producing NK T cells are biased towards IFN-gamma production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells. Eur. J. Immunol. 28: 1507-1515.
40. Leite-De-Moraes MC, Hameg A, Pacilio M, Koezuka Y, Taniguchi M, Van-Kaer L, Schneider E, Dy M and Herbelin A. 2001. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J. Immunol. 166: 945-951.
41. Leynaert B, Neukirch C, Jarvis D, Chinn S, Burney P and Neukirch F. 2001. Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am. J. Respir. Crit. Care Med. 164: 1829-1834.
42. Loza MJ, Metelitsa LS and Perussia B. 2002. NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production. Eur. J. Immunol. 32: 3453-3462.
43. Maeda T, Keino H, Asahara H, Taniguchi M, Nishioka K and Sumida T. 1999. Decreased TCR AV24AJ18+ double-negative T cells in rheumatoid synovium. Rheumatology (Oxford) 38: 186-188.
44. Magnan A, Mely L, Prato S, Vervloet D, Romagne F, Camilla C, Necker A, Casano B, Montero-Jullian F, Fert V, Malissen B and Bongrand P. 2000. Relationships between natural T cells, atopy, IgE levels, and IL-4 production. Allergy 55: 286-290.
45. Makino Y, Yamagata N, Sasho T, Adachi Y, Kanno R, Koseki H, Kanno M and Taniguchi M. 1993. Extrathymic development of V alpha 14-positive T cells. J. Exp. Med. 177: 1399-1408.
46. Matsuura A, Kinebuchi M, Chen HZ, Katabami S, Shimizu T, Hashimoto Y, Kikuchi K and Sato N. 2000. NKT cells in the rat: organ-specific distribution of NK T cells expressing distinct V alpha 14 chains. J. Immunol. 164: 3140-3148.
47. Mempel M, Flageul B, Suarez F, Ronet C, Dubertret L, Kourilsky P, Gachelin G and Musette P. 2000. Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire. Am. J. Pathol. 157: 509-523.
48. Oishi Y, Sakamoto A, Kurasawa K, Nakajima H, Nakao A, Nakagawa N, Tanabe E, Saito Y and Iwamoto I. 2000. CD4-CD8- T cells bearing invariant Valpha24JalphaQ TCR alpha-chain are decreased in patients with atopic diseases. Clin. Exp. Immunol. 119: 404-411.
49. Pied S, Roland J, Louise A, Voegtle D, Soulard V, Mazier D and Cazenave PA. 2000. Liver CD4- CD8- NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. J. Immunol. 164: 1463-1469.
50. Porcelli SA and Modlin RL. 1999. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17: 297-329.
51. Porcelli S, Gerdes D, Fertig AM and Balk SP. 1996. Human T cells expressing an invariant V alpha 24-J alpha Q TCR alpha are CD4- and heterogeneous with respect to TCR beta expression. Hum. Immunol. 48: 63-67.
52. Poulton LD, Smyth MJ, Hawke CG, Silveira P, Shepherd D, Naidenko OV, Godfrey DI and Baxter AG. 2001. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 13: 887-896.
53. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD and Holt PG. 1999. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 353: 196-200.
54. Prussin C and Foster B. 1997. TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J. Immunol. 159: 5862-5870,
55. Reinhardt C and Melms A. 1999. Elevated frequencies of natural killer T lymphocytes in myasthenia gravis. Neurology 52: 1485-1487.
56. Ritz SA, Cundall MJ, Gajewska BU, Alvarez D, Gutierrez-Ramos JC, Coyle AJ, McKenzie AN, Stampfli MR and Jordana M. 2002. Granulocyte macrophage colony-stimulating factor-driven respiratory mucosal sensitization induces Th2 differentiation and function independently of interleukin-4. Am. J. Respir. Cell Mol. Biol. 27: 428-435.
57. Saubermann LJ, Beck P, De-Jong YP, Pitman RS, Ryan MS, Kim HS, Exley M, Snapper S, Balk SP, Hagen SJ, Kanauchi O, Motoki K, Sakai T, Terhorst C, Koezuka Y, Podolsky DK and Blumberg RS. 2000. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119: 119-128.
58. Schofield L, McConville MJ, Hansen D, Campbell AS, Fraser-Reid B, Grusby MJ and Tachado SD. 1999. CD1d - restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283: 225-229.
59. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJ et al. 1995. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269: 227-230.
60. Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, Koezuka Y and Van-Kaer L. 1999. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163: 2373-2377.
61. Spada FM, Koezuka Y and Porcelli SA. 1998. CD1d-restricted recognition of synthetic glycolipid antigens by human Natural Killer T cells. J. Exp. Med. 188: 1529-1534.
62. Strachan DP. 1989. Hay fever, hygiene, and household size. BMJ 299: 1259-1260.
63. Sumida T, Maeda T, Taniguchi M, Nishioka K and Stohl W. 1998. TCR AV24 gene expression in double negative T cells in systemic lupus erythematosus. Lupus 7: 565-568.
64. Takahashi T, Nakamura K, Chiba S, Kanda Y, Tamaki K and Hirai H. 2003. Vα24 Natural Killer T cells are markedly decreased in atopic dermatitis patients. Hum. Immunol. 64: 586-592.
65. + T cell: a two-faced lymphocyte in immune modulation of the IL-4/IFN-γ paradigm. J. Clin. Immunol. 22: 270-280.
66. von Mutius E, Braun-Fahrländer C, Schierl R, Riedler J, Ehlermann S, Maisch S, Waser M and Nowak D. 2000. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin. Exp. Allergy 30: 1230-1234.
67. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL and Hafler DA. 1998. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391: 177-181.
68. Yoshimoto T and Paul WE. 1994. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179: 1285-1295.
69. Yoshimoto T, Bendelac A, Watson C, Hu-Li J and Paul WE. 1995. Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science 270: 1845-1847.
70. Zhang Y, Rogers KH and Lewis DB. 1996. Beta 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J. Exp. Med. 184: 1507-1512.